Organization Overview
Alternative names
aripiprazole (abilify) (1 trial)
atomoxetine (strattera) (1 trial)
azithromycin (zithromax) (2 trials)
bupropion (wellbutrin) (2 trials)
clarithromycin (biaxin) (1 trial)
clindamycin (cleocin) (1 trial)
immune globulin (human) (Gamastan) (1 trial)
inactivated influenza vaccine (3 trials)
levofloxacin (levaquin) (3 trials)
lidocaine (xylocaine) (3 trials)
linagliptin (tradjenta) (1 trial)
lisdexamfetamine (vyvanse) (1 trial)
lisinopril (zestril) (1 trial)
lithium (lithonate) (4 trials)
methadone (methadose) (4 trials)
natalizumab (tysabri) (1 trial)
nicardipine (cardene) (1 trial)
nitrofurantoin (furadantin) (1 trial)
nitroglycerin (transderm-nitro) (1 trial)
ocrelizumab (ocrevus) (1 trial)
pioglitazone (actos) (2 trials)
quetiapine (seroquel) (1 trial)
acetaminophen (tylenol) (1 trial)
aldesleukin (Proleukin) (8 trials)
allogeneic bone marrow (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (8 trials)
autologous hematopoietic stem cells (7 trials)
autologous mononuclear stem cell (1 trial)
bortezomib (velcade) (5 trials)
carboplatin (paraplatin) (18 trials)
celecoxib (celebrex) (8 trials)
cetuximab (erbitux) (6 trials)
cytarabine (cytosar-u) (14 trials)
dactinomycin (cosmegen) (2 trials)
dalfampridine (ampyra) (1 trial)
daunorubicin (cerubidine) (3 trials)
doxorubicin (Doxil) (19 trials)
etoposide (vepesid) (12 trials)
Filgrastim (neupogen) (2 trials)
fludarabine (fludara) (10 trials)
fluorouracil (efudex) (12 trials)
gabapentin (neurontin) (6 trials)
hydromorphone (diladid) (2 trials)
idarubicin (idamycin) (4 trials)
lamotrigine (lamictal) (1 trial)
lenalidomide (revlimid) (8 trials)
liraglutide (victoza) (6 trials)
melphalan (alkeran) (11 trials)
metoclopramide (reglan) (2 trials)
minocycline (minocin) (3 trials)
mitoxantrone (novantrone) (2 trials)
nebivolol (bystolic) (1 trial)
ondansetron (zofran) (1 trial)
oxycodone (oxycontin) (3 trials)
acetylsalicylic acid (aspirin) (3 trials)
allogeneic hematopoietic stem cells (Hemacord) (4 trials)
allogeneic lymphocytes (2 trials)
allopurinol (zyloprim) (1 trial)
alteplase (Activase) (1 trial)
alvac ny eso-1 vaccine (3 trials)
aminolevulinic acid (levulan) (4 trials)
antigen pulsed dendritic cells (3 trials)
anti-her2/her3 dendritic cell vaccine (1 trial)
atezolizumab (Tecentriq) (2 trials)
atorvastatin (lipitor) (1 trial)
autologous dendritic cells (2 trials)
autologous natural killer cells (1 trial)
autologous tumor infiltrating lymphocytes (1 trial)
autologous umbilical cord blood (5 trials)
bacille calmette-guerin (1 trial)
belantamab mafodotin (TECVAYLI) (1 trial)
belinostat (beleodaq) (1 trial)
bevacizumab (avastin) (13 trials)
bexarotene (targretin) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
calcitriol (rocaltrol) (8 trials)
capecitabine (xeloda) (12 trials)
carfilzomib (kyprolis) (1 trial)
chlorhexidine (hibitane) (2 trials)
cisplatin (platinol) (11 trials)
clonidine (catapres) (1 trial)
clopidogrel (plavix) (1 trial)
cyclosporine (sandimmune) (4 trials)
dacarbazine (dtic-dome) (1 trial)
dec-205/ny-eso-1 fusion protein cdx-1401 (5 trials)
decitabine (dacogen) (8 trials)
denileukin diftitox (ontak) (1 trial)
docetaxel (taxotere) (4 trials)
durvalumab (imfinzi) (1 trial)
dutasteride (avodart) (1 trial)
enzalutamide (xtandi) (4 trials)
erlotinib (tarceva) (3 trials)
etirinotecan pegol (Onzeald) (1 trial)
everolimus (zortress) (3 trials)
finasteride (Proscar) (1 trial)
fludeoxyglucose f-18 (2 trials)
fowlpox-ny-eso-1 vaccine (1 trial)
fulvestrant (faslodex) (2 trials)
gallium nitrate (ganite) (1 trial)
gemcitabine (gemzar) (18 trials)
inotuzumab ozogamicin (besponsa) (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
interferon alpha-2b (Intron-A) (8 trials)
irinotecan (Camptosar) (14 trials)
ketoconazole (nizoral) (3 trials)
methylene blue (proveblue) (6 trials)
methylphenidate (ritalin) (1 trial)
methylprednisolone (medrol) (5 trials)
milrinone (primacor) (1 trial)
mycophenolate (CellCept) (3 trials)
ny-eso-1(c259)t cells (1 trial)
ny-eso-1 reactive tcr retroviral vector transduced autologous pbl (1 trial)
obinutuzumab (gazyva) (1 trial)
octreotide (sandostatin) (2 trials)
ofatumumab (arzerra) (2 trials)
omacetaxine (synribo) (1 trial)
oxaliplatin (eloxatin) (13 trials)
oxymetazoline (ocuclear) (1 trial)
panobinostat (farydak) (2 trials)
parathyroid hormone (Natpara) (1 trial)
pazopanib (votrient) (1 trial)
pemetrexed (alimta) (4 trials)
peripheral blood lymphocytes (1 trial)
pexidartinib (Turallo) (1 trial)
porfimer (photofrin) (9 trials)
pralatrexate (folotyn) (1 trial)
propranolol (inderal) (6 trials)
rasburicase (Elitek) (1 trial)
recombinant vaccinia-ny-eso-1 vaccine (1 trial)
regorafenib (stivarga) (1 trial)
rimabotulinumtoxinB (Myobloc) (1 trial)
rosuvastatin (crestor) (1 trial)
sipuleucel-t (Provenge) (1 trial)
sorafenib (nexavar) (6 trials)
svn53-67/m57-klh peptide vaccine (3 trials)
talazoparib (talzenna) (2 trials)
temozolomide (temodar) (1 trial)
tetracaine (pontocaine) (1 trial)
tgfbdnrii-transduced autologous tumor infiltrating lymphocytes (1 trial)
thalidomide (Thalomid) (6 trials)
tipiracil (lonsurf) (3 trials)
tivozanib (Fotivda) (2 trials)
tremelimumab (Imjudo) (1 trial)
trifluridine (viroptic) (3 trials)
vandetanib (caprelsa) (1 trial)
venetoclax (venclexta) (1 trial)
altretamine (hexalen) (1 trial)
arsenic trioxide (trisenox) (2 trials)
autologous ny-eso-1-specific cd8-positive t lymphocytes (1 trial)
autologous tumor cell vaccine (1 trial)
binimetinib (mektovi) (1 trial)
bis-choline tetrathiomolybdate (1 trial)
cmv pp65 peptide-loaded alpha-type-1 polarized dendritic cell vaccine (1 trial)
dacomitinib (vizimpro) (1 trial)
dalteparin (fragmin) (1 trial)
darunavir (prezista) (2 trials)
eltrombopag (promacta) (1 trial)
fosamprenavir (lexiva) (1 trial)
genetically engineered ny-eso-1-specific t lymphocytes (1 trial)
hematoporphyrin derivative (1 trial)
hsp110-gp100 chaperone complex vaccine (1 trial)
incomplete freund's adjuvant (3 trials)
ipratropium (atrovent) (1 trial)
lung tumor associated antigen (1 trial)
methyl aminolevulinate (metvixia) (1 trial)
methyl bacteriopurpurinimide (1 trial)
onabotulinumtoxinA (Botox) (1 trial)
palbociclib (ibrance) (1 trial)
paricalcitol (zemplar) (2 trials)
pitavastatin (livalo) (1 trial)
albuterol (proventil) (1 trial)
anastrozole (arimidex) (1 trial)
beclomethasone (vanceril) (2 trials)
calfactant (infasurf) (2 trials)
emtricitabine (emtriva) (1 trial)
epinephrine (levophed) (1 trial)
glatiramer acetate (copaxone) (1 trial)
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Clear Cell (Phase 2)
Adenocarcinoma, Follicular (Phase 1)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma of Lung (Phase 1)
Albuminuria (Phase 4)
Anemia (Phase 3)
Anemia, Aplastic (Phase 3)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Refractory (Phase 1)
Anemia, Sickle Cell (Phase 2)
Aneurysm (Phase 2)
Asthma (Phase 4)
Astrocytoma (Phase 1)
Atherosclerosis (Phase 4)
Back Pain (Phase 4)
Barrett Esophagus (Phase 1)
Behavior, Addictive (Phase 4)
Bile Duct Neoplasms (Phase 2)
Blast Crisis (Phase 2)
Bone Diseases, Metabolic (Phase 2)
Brain Neoplasms (Phase 1)
Breast Carcinoma In Situ (Phase 2)
Breast Neoplasms (Phase 3)
Bronchiolitis (Phase 4)
Bronchiolitis, Viral (Phase 4)
Bronchitis (Phase 4)
Bronchitis, Chronic (Phase 4)
Burkitt Lymphoma (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 4)
Carcinoma, Acinar Cell (Phase 1)
Carcinoma, Adenoid Cystic (Phase 1)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Endometrioid (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma in Situ (Phase 1)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Mucoepidermoid (Phase 1)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Carcinoma, Verrucous (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Cholangiocarcinoma (Phase 2)
Chronic Pain (Phase 4)
Chronic Periodontitis (Phase 3)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 4)
Cystadenocarcinoma (Phase 2)
Cystadenocarcinoma, Serous (Phase 2)
Deficiency Diseases (Phase 4)
Delirium (Phase 4)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Depressive Disorder, Major (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diarrhea (Phase 1)
Disease (Phase 2)
Dizziness (Phase 3)
Ductus Arteriosus, Patent (Phase 2)
Emergence Delirium (Phase 4)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Esthesioneuroblastoma, Olfactory (Phase 1)
Fallopian Tube Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastroesophageal Reflux (Phase 3)
Gastrointestinal Neoplasms (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Gliosarcoma (Phase 2)
Graft vs Host Disease (Phase 2)
Granuloma (Phase 1)
Granulomatous Disease, Chronic (Phase 2)
Headache (Phase 1)
Headache Disorders (Phase 1)
Headache Disorders, Secondary (Phase 1)
Head and Neck Neoplasms (Phase 2)
Hemoglobinuria (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Hemorrhage (Phase 2)
Hernia (Phase 2)
Hernia, Diaphragmatic (Phase 2)
Hernias, Diaphragmatic, Congenital (Phase 2)
Hodgkin Disease (Phase 2)
Hypercholesterolemia (Phase 4)
Hyperemesis Gravidarum (Phase 3)
Hypereosinophilic Syndrome (Phase 1)
Hyperglycemia (Phase 3)
Hyperkinesis (Phase 4)
Hyperlipidemias (Phase 1)
Hyperlipoproteinemias (Phase 1)
Hyperplasia (Phase 1)
Hypersensitivity (Phase 1)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 2)
Hypogonadism (Phase 4)
Immunoblastic Lymphadenopathy (Phase 2)
Immunologic Deficiency Syndromes (Phase 4)
Infections (Phase 4)
Inflammation (Phase 4)
Insulin Resistance (Phase 4)
Intestinal Neoplasms (Phase 1)
Intestinal Obstruction (Phase 2)
Ischemia (Phase 1)
Ischemic Attack, Transient (Phase 1)
Keratoconus (Phase 3)
Kidney Diseases (Phase 4)
Kidney Neoplasms (Phase 3)
Laryngeal Diseases (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, Basophilic, Acute (Phase 1)
Leukemia, B-Cell (Phase 1)
Leukemia, Eosinophilic, Acute (Phase 1)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Accelerated Phase (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Plasma Cell (Phase 1)
Leukemia, T-Cell (Phase 2)
Liver Neoplasms (Phase 2)
Low Back Pain (Phase 4)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Maxillary Sinusitis (Phase 4)
Melanoma (Phase 2)
Meniere Disease (Phase 3)
Mesothelioma (Phase 2)
Mucositis (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Muscle Weakness (Phase 3)
Myasthenia Gravis (Phase 3)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Nervous System Neoplasms (Phase 1)
Neuroblastoma (Phase 2)
Neuroendocrine Tumors (Phase 2)
Neutropenia (Phase 2)
Obesity (Phase 3)
Obstetric Labor, Premature (Phase 1)
Oligodendroglioma (Phase 1)
Opioid-Related Disorders (Phase 4)
Oropharyngeal Neoplasms (Phase 2)
Osteoporosis (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 3)
Pain, Intractable (Phase 4)
Pain, Postoperative (Phase 3)
Pancreatic Neoplasms (Phase 2)
Papilloma (Phase 1)
Papilloma, Inverted (Phase 1)
Paranasal Sinus Neoplasms (Phase 2)
Parkinson Disease (Phase 1)
Periodontitis (Phase 3)
Peritoneal Neoplasms (Phase 2)
Persistent Fetal Circulation Syndrome (Phase 2)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 2)
Pleural Diseases (Phase 1)
Pneumonia (Phase 4)
Pneumonia, Bacterial (Phase 4)
Polycythemia (Phase 2)
Polycythemia Vera (Phase 2)
Polyuria (Phase 4)
Precancerous Conditions (Phase 3)
Preleukemia (Phase 3)
Premature Birth (Phase 2)
Primary Myelofibrosis (Phase 2)
Problem Behavior (Phase 4)
Prostatic Intraepithelial Neoplasia (Phase 3)
Prostatic Neoplasms (Phase 3)
Psychotic Disorders (Phase 4)
Puberty, Precocious (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Radiation Pneumonitis (Phase 2)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 1)
Red-Cell Aplasia, Pure (Phase 2)
Respiratory Insufficiency (Phase 2)
Respiratory Tract Infections (Phase 4)
Retinoblastoma (Phase 1)
Salivary Gland Neoplasms (Phase 1)
Sarcoma (Phase 3)
Sarcoma, Clear Cell (Phase 1)
Sarcoma, Kaposi (Phase 3)
Sarcoma, Synovial (Phase 2)
Schizophrenia (Phase 4)
Sclerosis (Phase 4)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Sinusitis (Phase 4)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Stroke (Phase 2)
Syndrome (Phase 3)
Temporomandibular Joint Disorders (Phase 2)
Thalassemia (Phase 2)
Thrombasthenia (Phase 2)
Thrombocythemia, Essential (Phase 1)
Thrombocytopenia (Phase 2)
Thrombocytosis (Phase 1)
Thymoma (Phase 2)
Thyroid Cancer, Papillary (Phase 1)
Thyroid Diseases (Phase 1)
Thyroid Neoplasms (Phase 1)
Tobacco Use Disorder (Phase 2)
Tongue Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Tuberculosis (Phase 1)
Urinary Bladder Neoplasms (Phase 4)
Urinary Tract Infections (Phase 4)
Uterine Cervical Neoplasms (Phase 2)
Uveal Neoplasms (Phase 2)
Vasospasm, Intracranial (Phase 4)
Vertigo (Phase 3)
Vesico-Ureteral Reflux (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Wilms Tumor (Phase 3)
Wiskott-Aldrich Syndrome (Phase 2)
Xerostomia (Phase 2)